Anja Coors

Dr. Anja Coors


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
John WilkinsonJohn Wilkinson
John Wilkinson
ABAlistair B. A. Boxall
Alistair B. A. Boxall
DKDana W. Kolpin
Dana W. Kolpin
KLKenneth M. Y. Leung
Kenneth M. Y. Leung
RLRacliffe W. S. Lai
Racliffe W. S. Lai
Charles TetaCharles Teta
Charles Teta
Environmental exposure to active pharmaceutical ingredients (APIs) can have negative effects on the health of ecosystems and humans. While numerous studies have monitored APIs in rivers, these employ different analytical methods, measure different APIs, and have ignored many of the countries of the world. This makes it difficult to quantify the scale of the problem from a global perspective. Furthermore, comparison of the existing data, generated for different studies/regions/continents, is challenging due to the vast differences between the analytical methodologies employed. Here, we present a global-scale study of API pollution in 258 of the world’s rivers, representing the environmental influence of 471.4 million people across 137 geographic regions. Samples were obtained from 1,052 locations in 104 countries (representing all continents and 36 countries not previously studied for API contamination) and analyzed for 61 APIs. Highest cumulative API concentrations were observed in sub-Saharan Africa, south Asia, and South America. The most contaminated sites were in low- to middle-income countries and were associated with areas with poor wastewater and waste management infrastructure and pharmaceutical manufacturing. The most frequently detected APIs were carbamazepine, metformin, and caffeine (a compound also arising from lifestyle use), which were detected at over half of the sites monitored. Concentrations of at least one API at 25.7% of the sampling sites were greater than concentrations considered safe for aquatic organisms, or which are of concern in terms of selection for antimicrobial resistance. Therefore, pharmaceutical pollution poses a global threat to environmental and human health, as well as to delivery of the United Nations Sustainable Development Goals.

6 January 2016 in Environmental Sciences Europe
Verified
Journal Article
Open access
PDF file
KDKaren Duis
Karen Duis
ACAnja Coors
Anja Coors
Due to the widespread use and durability of synthetic polymers, plastic debris occurs in the environment worldwide. In the present work, information on sources and fate of microplastic particles in the aquatic and terrestrial environment, and on their uptake and effects, mainly in aquatic organisms, is reviewed. Microplastics in the environment originate from a variety of sources. Quantitative information on the relevance of these sources is generally lacking, but first estimates indicate that abrasion and fragmentation of larger plastic items and materials containing synthetic polymers are likely to be most relevant. Microplastics are ingested and, mostly, excreted rapidly by numerous aquatic organisms. So far, there is no clear evidence of bioaccumulation or biomagnification. In laboratory studies, the ingestion of large amounts of microplastics mainly led to a lower food uptake and, consequently, reduced energy reserves and effects on other physiological functions. Based on the evaluated data, the lowest microplastic concentrations affecting marine organisms exposed via water are much higher than levels measured in marine water. In lugworms exposed via sediment, effects were observed at microplastic levels that were higher than those in subtidal sediments but in the same range as maximum levels in beach sediments. Hydrophobic contaminants are enriched on microplastics, but the available experimental results and modelling approaches indicate that the transfer of sorbed pollutants by microplastics is not likely to contribute significantly to bioaccumulation of these pollutants. Prior to being able to comprehensively assess possible environmental risks caused by microplastics a number of knowledge gaps need to be filled. However, in view of the persistence of microplastics in the environment, the high concentrations measured at some environmental sites and the prospective of strongly increasing concentrations, the release of plastics into the environment should be reduced in a broad and global effort regardless of a proof of an environmental risk.


19 October 2009 in Aquatic Toxicology
Verified
Journal Article
Closed access
ACAnja Coors
Anja Coors
JVJoost Vanoverbeke
Joost Vanoverbeke
TBTom De Bie
Tom De Bie
LMLuc De Meester
Luc De Meester

16 December 2008 in Oikos
Verified
Journal Article
Closed access
PDF file
ACAnja Coors
Anja Coors
EDEllen Decaestecker
Ellen Decaestecker
MJMieke Jansen
Mieke Jansen
LMLuc De Meester
Luc De Meester

1 February 2014 in Science of The Total Environment
Verified
Journal Article
Closed access
AMAndré Macherius
André Macherius
DLDavid R. Lapen
David R. Lapen
TRThorsten Reemtsma
Thorsten Reemtsma
JRJoerg Roembke
Joerg Roembke
ETEdward Topp
Edward Topp
ACAnja Coors
Anja Coors